AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. No specific financial details, figures, or material business updates were mentioned in the announcement. This appears to be a routine regulatory compliance filing related to the company's dealings with depositories. The exact nature of the certificate (such as reconciliation of shareholding or investor complaint status) is not specified in the headline.
This is likely a routine compliance filing with no direct impact on shareholders or stock price. Investors should monitor for any further details on the specific certificate submitted.